Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
Wed, May 14, 2025
Tue, May 13, 2025
[ Tue, May 13th ] - WSAZ
Summer science experiments
Mon, May 12, 2025
Sun, May 11, 2025
Sat, May 10, 2025
Fri, May 9, 2025
Thu, May 8, 2025
Wed, May 7, 2025
Tue, May 6, 2025
Mon, May 5, 2025

Tiziana Life Sciences reports purchase of shares by chairman (TLSA:NASDAQ)


//science-technology.news-articles.net/content/2 .. -purchase-of-shares-by-chairman-tlsa-nasdaq.html
Published in Science and Technology on Monday, May 12th 2025 at 8:42 GMT by   Print publication without navigation

  • Tiziana Life Sciences (TLSA) on Monday said that its Executive Chairman and Founder,
  • Gabriele Cerrone, has purchased 15,000 common shares at $1.55 per share, bringing his total holding to 43,252,143 common shares, which is 37.02% of issued share capital.

Tiziana Life Sciences announced that its Chairman, Gabriele Cerrone, purchased 2.5 million ordinary shares of the company on June 23, 2023, at a price of $0.80 per share, totaling an investment of $2 million. This transaction increased Cerrone's total ownership in Tiziana to approximately 8.9% of the company's outstanding shares. The purchase reflects Cerrone's confidence in Tiziana's future prospects, particularly as the company advances its clinical programs, including the development of foralumab, a fully human anti-CD3 monoclonal antibody, for the treatment of multiple sclerosis and other autoimmune and inflammatory diseases.

Read the Full Seeking Alpha Article at:
[ https://seekingalpha.com/news/4446344-tiziana-life-sciences-reports-purchase-of-shares-by-chairman ]